At Stocks Down Under, we're as concerned about the lack of ASX IPOs as private equity is. But this author's jaw dropped upon ...
Visit the website of BridgeBio Pharma (NDQ:BBIO), and you'll find it describes itself as 'a unique biotechnology company advancing genetic medicines via a ...
Ascendis Pharma (NDQ:ASND) has a portfolio of drugs that could be the most important to hit the market since BioMarin's Voxzogo (vosoritide). This became one ...
NEXTDC (ASX:NXT) has cut FY27 revenue and EBITDA guidance by around A$140m after Jemena suspended power works at its M3 ...
North America CEO Kristie Keast is leaving at the end of October 2026, with Sue Stark stepping in as interim leader.
LinQ Minerals (ASX:LNQ) reports 429m of visual mineralisation at Gidginbung South, with assays due in 6 to 8 weeks to confirm ...
Sigma Healthcare (ASX:SIG) posted 12.1% Chemist Warehouse sales growth and 9.8% like-for-like after cycling the GLP-1 boost ...
Roivant Sciences (NASDAQ:ROIV) has spent the past decade attempting something uncommon in the biotech space. Namely, creating a system for repeatedly building ...
Apple (AAPL) stock falls after Loop Capital cuts its target to US$330 and warns 13 million planned iPhone shipments may not recover. What investors should know.
Can be BeOne Medicines (NDQ:ONC) become a global oncology superpower? For many aspirants, the biggest impediment is the lack ...
SpaceX (NSDQ:SPCX) delivered US$14.6bn Q3 revenue as Super Intelligence turned profitable, but investors still face a ...
SpaceX (SPCX) beats Q3 estimates as AI revenue surges 830% to US$7.56 billion. Discover what drove the earnings jump and why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results